Chembio Diagnostic Systems, Inc. (NASDAQ: CEMI) develops, manufactures, licenses and markets point-of-care (POC) diagnostic tests and technology for the detection of infectious diseases. Founded in 1985 to develop products used in diagnostic labs, Chembio entered the POC testing field in the late 1990's and, in 2002, focused its business to participate in the emerging global need and opportunity for rapid HIV tests. The Company became public in 2004 and is now a leading employer on Long Island, with approximately 170 employees. Revenues during 2011 reached nearly $20MM. Chembio has been profitable since 2009 and anticipates continued revenue growth and profitability in 2012.
Chagas STAT-PAK Rapid Assay Chembio Diagnostic Systems, Inc.s Chagas STAT-PAK Rapid Assay is easy to perform, requires no cold chain storage, uses a minimal sample size, and provides visual detection of antibodies to T. cruzi. Read More
DPP HIV 1/2 Assay Chembio has developed a new, innovative diagnostic assay based on the patented DPP technology for the rapid detection of HIV 1 and HIV 2 antibodies in all blood matrices and oral fluid. The Chembio DPP HIV 1/2 Assay is a single-use immuno-chromatographic, rapid test for the detection of antibodies to Human Immunodeficiency Virus Types 1 and 2 (HIV 1/2) in oral fluid, finger-stick whole blood, venous whole blood, serum, or plasma samples. Read More
HIV 1/2 STAT-PAK Assay Chembio HIV 1/2 STAT-PAK tests are easy-to-perform, single-use diagnostic tests for the rapid (20 minutes or less), visual detection of antibodies to HIV 1 and HIV 2 at point-of-care (POC). Read More
SURE CHECK HIV 1/2 Assay Chembio Diagnostic Systems, Inc.s SURE CHECK HIV 1/2 is a unique, easy-to-use, self-contained, single-use collection and testing device for the rapid, visual detection of antibodies to HIV 1 and HIV 2. Read More
Insights from over 1,000 patients reveal that even though patients are taking an increasingly active role in managing their healthcare, they still rely on an existing provider to select a specialist for them.
If you see Medicare patients, your practice will be reimbursed differently. The new policy goes into effect on January 1, 2017. Elation has dug deep into the details of the new Medicare rules, known as MACRA, and how it might affect your business. Read on to find out all you need to know.
Tackling administrative challenges in healthcare enterprises often means big resource commitments that take years to pay off. But on-call scheduling technology can reverse that equation, delivering impressive ROI from a relatively modest investment of time and money.